Etelcalcetide use in patients with diabetic nephropathy might protect against development of adynamic bone disease, according to investigators.
More than two-thirds of patients experienced a more than 5% weight loss with 12 months of etelcalcetide treatment.
In a large, single-center study, severe hypocalcemia developed in 1 in 4 patients who underwent total parathyroidectomy without autotransplantation.
In a study, 24% of women with any urinary incontinence reported that the condition affected their daily activities.
Only 67% of Black patients on dialysis who responded to an online survey had a nephrologist involved in their care, compared with 97% of White respondents.
Routine pain assessments using validated scales are vital to develop personalized management strategies, according to investigators.
Non-linear renal function decline frequently occurs in patients with type 2 diabetes and is associated with faster progression to end-stage kidney disease.
The prevalence of hypertension and albuminuria in pediatric patients with type 2 diabetes varies by race.
Patient characteristics, such as dialysis use and diabetes status, appeared to be influential factors.